Know Cancer

or
forgot password

    • cancer clinical trials in rancho cucamonga, CA

    • Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Pain, Prostate Cancer
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Breast Cancer
    Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Breast Cancer
    Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Breast Cancer
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Colorectal Cancer
    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Esophageal Cancer, Gastric Cancer
    A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Metastatic Pancreatic Adenocarcinoma
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Non Small Cell Lung Cancer
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Pancreatic Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Colorectal Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Colorectal Cancer
    Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Multiple Myeloma
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Non Small Cell Lung Carcinoma
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Prostate Cancer
    A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Breast Cancer
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Non-Hodgkin's Lymphoma
    Treating Chronic Insomnia in Breast Cancer Patients
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Chronic Insomnia
    Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Multiple Myeloma
    A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Metastatic Breast Cancer
    Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma
    Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Metastatic Prostate Cancer
    Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Renal Cell Carcinoma
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Wilshire Oncology Medical Group, Inc.
    Rancho Cucamonga, California 91730
    Myelodysplastic Syndrome (MDS)